Next |
home / stock / tcrx / tcrx message board
Subject | By | Source | When |
---|---|---|---|
Quote, they have presentation on 17th, | crazy horse 0 | investorshub | 05/10/2023 5:08:44 PM |
Also another huge catalyst is waiting on, once | dinogreeves | investorshub | 05/10/2023 4:02:47 PM |
As of yesterday it was higher than 23%, | dinogreeves | investorshub | 05/10/2023 3:51:50 PM |
5% shorted ? Where will it squeeze. | IOUBLOKE1 | investorshub | 05/10/2023 3:43:12 PM |
Crazy Horse, brother, I have been watching the | dinogreeves | investorshub | 05/10/2023 3:31:20 PM |
Appreciate your input | crazy horse 0 | investorshub | 05/10/2023 3:29:30 PM |
The idea of $TCRX running like LGV*N did | dinogreeves | investorshub | 05/10/2023 1:44:49 PM |
Sounds even better, now that you are in | dinogreeves | investorshub | 05/10/2023 12:41:00 PM |
Baker Brothers is going to take them for | dinogreeves | investorshub | 05/10/2023 12:39:14 PM |
Gotta imagine huge intraday short percentage yesterday | Awl416 | investorshub | 05/10/2023 12:17:26 PM |
Sounds good | crazy horse 0 | investorshub | 05/10/2023 2:27:07 AM |
Baker Brothers top institutional investors, they know where | dinogreeves | investorshub | 05/10/2023 2:19:36 AM |
Price targets 14-15 within the next 6-9 months. | dinogreeves | investorshub | 05/10/2023 1:59:03 AM |
Not sure if these TIP presentations include any | jondoeuk | investorshub | 05/09/2023 11:26:16 PM |
Multi-year partnership with AMGN https://www.prnewswire.com/news-releases/amgen- | jondoeuk | investorshub | 05/09/2023 11:05:04 PM |
MomentumIts gaining up | jondoeuk | investorshub | 05/09/2023 10:30:20 PM |
$TCRX Excellent Move | Capitalvaluetrade | investorshub | 05/09/2023 8:42:16 PM |
Baker Brothers, going to annihilate the shorts. | dinogreeves | investorshub | 05/09/2023 7:15:46 PM |
https://stockcharts.com/h-sc/ui?s=TCRX&p=D&yr=0&mn=6&dy=0&id=p38090673899 htt | surf1944 | investorshub | 05/09/2023 5:46:39 PM |
$TCRX: If this puppy doesn't Close today at | Invest-in-America | investorshub | 05/09/2023 2:47:25 PM |
News, Short Squeeze, Breakout and More Instantly...
TScan Therapeutics Inc. Company Name:
TCRX Stock Symbol:
NYSE Market:
First patient dosed in Phase 1 clinical trial for the treatment of solid tumors; initial data anticipated in 2024 All treatment-arm patients in th...
First patient dosed in Phase 1 clinical trial for the treatment of solid tumors; initial data anticipated in 2024 All treatment-arm patients in the Phase 1 heme program remain relapse-free with no detectable disease, with a median follow-up of >10 months Closed upsized underw...
Patient dosed with TSC-20 3 -A0201 targeting cancer-associated antigen PRAME On-track to report initial data from the solid tumor clinical trial in 2024 WALTHAM, Mass., May 09, 2024 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage...